Infinity Pharmaceuticals, Inc. Operating Lease Cost
Infinity Pharmaceuticals, Inc. reported Operating Lease Cost of $700.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2023-03-28
- Infinity Pharmaceuticals, Inc. operating lease, cost for the quarter ending 2019-12-31 was $200.00K.
- Infinity Pharmaceuticals, Inc. operating lease, cost for the quarter ending 2019-09-30 was $200.00K.
- Infinity Pharmaceuticals, Inc. operating lease, cost for the quarter ending 2019-06-30 was $300.00K.
- Infinity Pharmaceuticals, Inc. operating lease, cost for the quarter ending 2019-03-31 was $100.00K.
- Infinity Pharmaceuticals, Inc. operating lease, cost for fiscal 2022 was $700.00K, a 0.00% change from fiscal 2021.
- Infinity Pharmaceuticals, Inc. operating lease, cost for fiscal 2021 was $700.00K, a 0.00% change from fiscal 2020.
- Infinity Pharmaceuticals, Inc. operating lease, cost for fiscal 2020 was $700.00K, a 12.50% decline from fiscal 2019.
- Infinity Pharmaceuticals, Inc. operating lease, cost for fiscal 2019 was $800.00K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2022-12-31 | $700.00K 10-K · filed 2023-03-28 | |||
| 2021-12-31 | $700.00K 10-K · filed 2023-03-28 | |||
| 2020-12-31 | $700.00K 10-K · filed 2022-03-29 | |||
| 2019-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $400.00K derived: sum of 2 quarters · filed 2021-03-16 | $700.00K derived: sum of 3 quarters · filed 2021-03-16 | $800.00K 10-K · filed 2021-03-16 |
| 2019-09-30 | $200.00K 10-Q · filed 2019-10-30 | $500.00K derived: sum of 2 quarters · filed 2019-10-30 | $600.00K 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $300.00K 10-Q · filed 2019-07-30 | $400.00K 10-Q · filed 2019-07-30 | ||
| 2019-03-31 | $100.00K 10-Q · filed 2019-05-07 |